Pioglitazone hydrochloride stimulates insulin secretion in HIT-T 15 cells by inducing Ca2+ influx

Journal of Endocrinology

Volumn 150, Issue 1, 1996, Pages 107-111

  Ohtani, K ^a   Shimizu, H ^a,b   Tanaka, Y ^a   Sato, N ^a   Mori, M ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NIFEDIPINE; PIOGLITAZONE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL;

EID: 0030056559     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1500107     Document Type: Article

References (16)

1. Ciaraldi TP, Gilmore A, Olefsky JM, Goldberg M & Heidenreich KA 1990 In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism 39 1056-1062.
2. Colca JR, Wyse BM, Sawada G, Jodelis KS, Connell CL, Fletcher-McGruder BL & Palazuk BJ 1988 Ciglitazone, a new hyperglycemic agent: early effects on the pancreatic islets of ob/ob mice. Metabolism 37 276-280.
3. Hofmann C, Lorenz K & Colca JR 1991 Glucose transport deficiency in diabetic animals is corrected by treatment with the oral anti-hyperglycemic agent, pioglitazone. Endocrinology 129 1915-1925.
4. Hofmann CA, Edwards III CW, Hillman RM & Colca JR 1992 Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression. Endocrinology 130 735-740.
5. Horikoshi H, Fujiwara T, Yoshioka T, Yoshioka S, Wada M & Fukami M 1990 Pharmacological characteristic of new antidiabetic agent CS-045 in diabetic animals. In Frontiers in Diabetes Research. Lessons From Animal Diabetes, pp 320-324. Ed E Shafrir. London: Smith-Gordon.
6. Kellerer M, Kroder G, Tippmer S, Berti L, Kiehn R, Mosthaf L & Haring H 1994 Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes 43 447-453.
7. Kemnitz JW, Elson DF, Roecker EB, Baum ST, Bergman RN & Meglasson MD 1994 Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure in obese, insulin-resistant rhesus monkeys. Diabetes 43 204-211.
8. Kobayashi M, Iwanishi M, Egawa K & Shigeta Y 1992 Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes 41 476-483.
9. Malaisse WJ & Sener A 1981 Calcium-antagonists and islet function. XII. Comparison between nifedipine and chemically related drugs. Biochemical Pharmacology 30 1039-1041.
10. Matsuda K, Okamoto Y, Tsuura Y, Kato S, Miura T, Tsuda K, Horikoshi H, Ishida H & Seino Y 1995 Effects of troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide. Diabetologia 38 24-30.
11. Sandouk T, Reda D & Hofmann C 1993 The diabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. Endocrinology 133 352-359.
12. Santerre RF, Cook RA, Crisel RMD, Sharp JD, Schmidt RJ, Williams DC & Wilson CP 1981 Insulin synthesis in a cloned cell line of simian virsu 40-transformed hamster pancreatic beta cells. Proceedings of the National Academy of Sciences of the USA 78 4339-4343.
13. + channel in insulin secreting cells. Journal of Biological Chemistry 262 15840-15844.
14. Sohda T, Mizuno K, Momose Y, Ikeda H, Fujita T & Meguro K 1992 Characterization of a new oral antidiabetic agent CS-045. Journal of Medical Chemistry 35 2617-2626.
15. Weinstein SP, Holand A, O'Boyle E & Haber RS 1993 Effects of thiazolidines on glucose-induced resistance and GLUT4 glucose transporter expression in rat skeletal muscle. Metabolism 42 1365-1369.
16. Zhang F, Sowers JR, Ram JL, Standley PR & Peuler JD 1994 Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension 24 170-175.